News Room

Back in January, we told you about a different kind of COVID vaccine that had just been approved for use in India. The vaccine, called Corbevax, had some very attractive properties: It's low-cost, easy to make using well-established biotech processes — and patent-free.

Titled “What Happens When a Retailer Drops a Product Category? Investigating the Consequences of Ending Tobacco Sales,” the study demonstrated the role of tobacco as a traffic driver to brick-and-mortar stores, and negative microeconomic consequence a ban would have, whether voluntary or not.

The Centers for Disease Control and Prevention leadership recently announced the agency will undergo an overhaul to address the causes of repeated missteps during the pandemic. For how that might actually look, Federal News Network’s Eric White spoke to Julie Swann on the Federal Drive with Tom Temin.  Swann is a professor of industrial and systems engineering at N.C. State. She’s done much research in this area, including on behalf of CDC itself.

The summer of 2022 will go down on record with an unprecedented number of flight delays and cancellations. Few travelers have been spared from the air travel chaos, with everyone’s patience pushed to the edge.

Two electrifying moves in recent weeks have the potential to ignite electric vehicle demand in the United States. First, Congress passed the Inflation Reduction Act, expanding federal tax rebates for EV purchases. Then California approved rules to ban the sale of new gasoline-powered cars by 2035.